Literature DB >> 10615832

Low fasting insulin levels in Eskimos compared to American Indians: are Eskimos less insulin resistant?

C D Schraer1, P M Risica, S O Ebbesson, O T Go, B V Howard, A M Mayer.   

Abstract

The prevalence of diabetes is relatively low among Eskimo people in contrast to that in other Native American populations. The reasons for this may be partially explained by differences in the occurrence of insulin resistance. In this report we compare fasting insulin levels, which correlate with insulin resistance, in Alaskan Eskimo subjects to those among American Indians. After adjusting for age, gender, and body mass index, and using identical laboratory methods, we found significantly lower insulin levels among Eskimo compared with Indian participants with normal glucose tolerance. Among Eskimos insulin levels increased with increasing body mass index, were higher for women than men, and did not appreciably change with age. Our data suggest that among Eskimo people insulin resistance may be less prevalent or severe than among American Indians, but that obesity is associated with increased insulin resistance. Future analyses will examine the association between insulin levels and other correlates of the insulin resistance syndrome. We hope that by further characterizing insulin resistance or sensitivity among Eskimo people, specific recommendations can be made that will lead to cardiovascular risk factor reduction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10615832

Source DB:  PubMed          Journal:  Int J Circumpolar Health        ISSN: 1239-9736            Impact factor:   1.228


  7 in total

1.  CDKAL1 and HHEX are associated with type 2 diabetes-related traits among Yup'ik people.

Authors:  Yann C Klimentidis; Dominick J Lemas; Howard H Wiener; Diane M O'Brien; Peter J Havel; Kimber L Stanhope; Scarlett E Hopkins; Hemant K Tiwari; Bert B Boyer
Journal:  J Diabetes       Date:  2013-10-29       Impact factor: 4.006

2.  Genetic polymorphisms in carnitine palmitoyltransferase 1A gene are associated with variation in body composition and fasting lipid traits in Yup'ik Eskimos.

Authors:  Dominick J Lemas; Howard W Wiener; Diane M O'Brien; Scarlett Hopkins; Kimber L Stanhope; Peter J Havel; David B Allison; Jose R Fernandez; Hemant K Tiwari; Bert B Boyer
Journal:  J Lipid Res       Date:  2011-11-01       Impact factor: 5.922

3.  Linkage and association analysis of obesity traits reveals novel loci and interactions with dietary n-3 fatty acids in an Alaska Native (Yup'ik) population.

Authors:  Laura Kelly Vaughan; Howard W Wiener; Stella Aslibekyan; David B Allison; Peter J Havel; Kimber L Stanhope; Diane M O'Brien; Scarlett E Hopkins; Dominick J Lemas; Bert B Boyer; Hemant K Tiwari
Journal:  Metabolism       Date:  2015-03-05       Impact factor: 8.694

4.  Metabolic syndrome: prevalence among American Indian and Alaska native people living in the southwestern United States and in Alaska.

Authors:  Catherine Schumacher; Elizabeth D Ferucci; Anne P Lanier; Martha L Slattery; Cynthia D Schraer; Terry W Raymer; Denise Dillard; Maureen A Murtaugh; Lillian Tom-Orme
Journal:  Metab Syndr Relat Disord       Date:  2008-12       Impact factor: 1.894

5.  Endogenous ω-3 polyunsaturated fatty acid production confers resistance to obesity, dyslipidemia, and diabetes in mice.

Authors:  Jie Li; Fanghong R Li; Dong Wei; Wei Jia; Jing X Kang; Maja Stefanovic-Racic; Yifan Dai; Allan Z Zhao
Journal:  Mol Endocrinol       Date:  2014-06-30

6.  Prevalence of smoking and its relationship with carotid atherosclerosis in Alaskan Eskimos of the Norton Sound region: the GOCADAN study.

Authors:  David J Kaufman; Mary J Roman; Richard B Devereux; Richard R Fabsitz; Jean W MacCluer; Bennett Dyke; Sven O E Ebbesson; Charlotte R Wenger; Terry Romanesko; Anthony G Comuzzie; Barbara V Howard
Journal:  Nicotine Tob Res       Date:  2008-03       Impact factor: 4.244

Review 7.  An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity.

Authors:  Artemis P Simopoulos
Journal:  Nutrients       Date:  2016-03-02       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.